8 June 2016Americas

BIO 2016 video interview: Merck counsel on biosimilar issues

Casey Thampoe, managing IP counsel for biologics and vaccines at Merck & Co, was one of a panel of speakers on a session outlining the biosimilars situation in the US.

Speaking to LSIPR, Thampoe provided an overview of the session and what was discussed.

You can read our report of the session here.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk